Global Theranostics Market Analysis and Forecast: Trends Shaping the Future 2024-2033

The Business Research Company’s Theranostics Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 17, 2024 /EINPresswire.com/ -- The theranostics market size is projected to grow from $98.91 billion in 2023 to $110.41 billion in 2024, at a compound annual growth rate (CAGR) of 11.6%. This growth can be attributed to advancements in molecular imaging, the shift to value-based healthcare, and its integration in oncology. Moving forward, the market is expected to continue its rapid expansion, reaching $164.38 billion by 2028, with a CAGR of 10.5%. Factors driving this growth include the rise in precision medicine initiatives, expanding applications beyond oncology, population aging and chronic diseases, advancements in biomarker discovery, and strong government support and funding.

Rising Prevalence of Cancer Drives Market Growth
The rising prevalence of cancer globally is a significant driver for the theranostics market. Cancer affects various organs and remains a leading cause of morbidity and mortality worldwide. Theranostics, combining therapeutics and diagnostics, offers personalized treatment options by leveraging diagnostic insights to tailor therapies effectively. This approach is pivotal in managing cancer and chronic diseases, fostering innovation in healthcare. According to the National Cancer Institute, approximately 18.1 million individuals in the US are cancer survivors, with numbers projected to rise, underscoring the growing demand for effective theranostic solutions.

Explore the global theranostics market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=10823&type=smp

Key Players and Market Trends
Major players in the theranostics market such as Abbott Laboratories, Thermo Fisher Scientific Inc., and Roche Diagnostics Corporation are focusing on innovative products like molecular targeted radiopharmaceuticals (MTRPs) to gain competitive advantage. For instance, Applied Molecular Therapeutics launched 177Lu (n.c.a.)-PSMA-Therapy, a targeted radiopharmaceutical for prostate cancer treatment, highlighting advancements in precision medicine.

Segments
• Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases
• Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies
• End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Geographical Insights: Asia-Pacific Leading the Market
North America dominated the theranostics market in 2023, while Asia-Pacific is expected to emerge as the fastest-growing region in the forecast period. Detailed regional dynamics and growth opportunities are covered comprehensively in the report.

Access the complete report for in-depth analysis of the global theranostics market:
https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

Theranostics Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Theranostics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on theranostics market size, theranostics market drivers and trends, theranostics market major players, competitors' revenues, market positioning, and market growth across geographies. The theranostics market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Tumor Ablation Therapy Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Aromatherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aromatherapy-global-market-report

Home Infusion Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Dinesh Kumar
The Business Research Company
+918897263534
info@tbrc.info

The Future of Occupational Medicines Market